Search Results 181-190 of 18622 for Appendix

  1. Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH - Mayo Clinic

    See Appendix 5. 13. Is receiving or has received any other investigational agent(s)/device(s) in the last 30 days. Note: Other protocol defined Inclusion ...

  2. Ablation therapy - Doctors & Departments - Mayo Clinic

    ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Stage 4 colorectal cancer, Recurrent cancer, Duodenal cancer, Bile duct injury, Bile duct ...

  3. Hypnosis - Mayo Clinic

    Related. Alternative cancer treatments: 11 options to consider · Appendix cancer · Brain ...

  4. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Recurrent cancer, Liver metastasis, Duodenal cancer, Bile duct injury, Bile duct cyst ...

  5. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Stage 4 colorectal cancer, Recurrent cancer, Duodenal cancer, Bile duct injury, Bile duct ...

  6. Barium sulfate (oral route) - Side effects & uses - Mayo Clinic

    Asthma, hay fever, or other allergies, history of—May increase risk for allergic reaction to occur again. Appendicitis (inflammation of the appendix) or ...

  7. A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer - Mayo Clinic

    ... (Appendix III); moderate to severe objective evidence of cardiovascular disease • Myocardial infarction or stroke <6 months prior to pre-registration ...

  8. Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis - Mayo Clinic

    Subjects with an MMT-8 score ≤ 66 (see Appendix B) must also have at least 2 other core set measures meeting the criteria listed below. Subjects with an ...

  9. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

    An indication for treatment per IWCLL 2018 criteria (Appendix 2) and radiographically measurable disease (at least 1 lesion > 1.5cm in diameter). Adequate ...

  10. A Study To Evaluate Efficacy, Safety And Tolerability Of CK-2127107 In Patients With Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Use of a medication that is an OCT1/OCT2 substrate within 7 days (see Appendix B). Participating Mayo Clinic locations. Study statuses change often. Please ...